A Historic Milestone: 2MG Inc. Secures 9 CPR Approvals in a Single Day

March 10, 2026 marks a proud and remarkable moment for 2MG Inc. and its dedicated team.
On this day, the company’s Regulatory and In-Licensing Team achieved an extraordinary milestone—securing nine (9) Certificates of Product Registration (CPR) in a single day from the Philippine Food and Drug Administration. This accomplishment highlights the team’s expertise, persistence, and commitment to meeting the highest regulatory standards in the pharmaceutical industry.
Obtaining a Certificate of Product Registration is a rigorous and highly detailed process that ensures medicines meet strict requirements for quality, safety, and efficacy before they can be made available to patients. Achieving nine approvals in a single day is an exceptional milestone and may represent one of the most significant regulatory achievements in the history of the Philippine pharmaceutical sector.
Our team of regulatory experts is especially recognized for its proficiency in registering critical cancer medicines. Cancer treatments are often among the most challenging therapies to access due to their complexity and cost. By successfully navigating rigorous regulatory pathways, we help ensure that these life-saving treatment options reach Filipino patients who need them most.
Alongside oncology therapies, the team also works on rare disease and blood disorder medicines, broadening access to treatments that are often difficult to obtain within the healthcare system.
Beyond product registration, our regulatory affairs pharmacists uphold strict compliance with both local and global quality standards. Their expertise ensures that every medicine we register and deliver meets the highest requirements for safety, effectiveness, and regulatory compliance, aligned with the standards of the Philippine Food and Drug Administration and other international regulatory authorities.
Working closely with our business development team, we also build strong partnerships with leading global manufacturers and suppliers. Through these collaborations, we introduce innovative, world-class oncology medicines into the Philippine healthcare system—bridging the gap between global medical breakthroughs and patient access.
Our commitment extends to supporting hospitals, pharmacies, and healthcare providers by ensuring timely approvals, reliable distribution, and continuous regulatory monitoring of cancer therapies and other life-saving medicines.
Through these collective efforts, 2MG Inc. continues to expand access to critical treatments and make a meaningful difference in the lives of Filipino patients and their families—especially those battling cancer.